| Tag | Content |
|---|
EnhancerAtlas ID | HS018-13083 |
Organism | Homo sapiens |
Tissue/cell | CD19+ |
Coordinate | chr2:145212300-145215260 |
SNPs | | Number: 2 | ID | Chromosome | Position | Genome Version |
|
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| IRF1 | MA0050.2 | chr2:145213316-145213337 | TCTCTCTTTCTCTTTCTCTCC | + | 6.28 | | Pou2f3 | MA0627.1 | chr2:145213258-145213274 | TATAATTTGCATAGCA | - | 6.32 | | Sox6 | MA0515.1 | chr2:145213678-145213688 | CCATTGTTTT | + | 6.02 | | ZNF263 | MA0528.1 | chr2:145213323-145213344 | TTCTCTTTCTCTCCCTCCCCA | - | 6.64 |
|
| | Number of super-enhancer constituents: 23 | ID | Coordinate | Tissue/cell |
| SE_00013 | chr2:145208646-145220907 | Adipose_Nuclei | | SE_03135 | chr2:145208774-145218083 | Brain_Angular_Gyrus | | SE_03858 | chr2:145208840-145232427 | Brain_Anterior_Caudate | | SE_04763 | chr2:145177825-145243674 | Brain_Cingulate_Gyrus | | SE_05778 | chr2:145209021-145234668 | Brain_Hippocampus_Middle | | SE_06674 | chr2:145177449-145244019 | Brain_Hippocampus_Middle_150 | | SE_07715 | chr2:145204565-145243004 | Brain_Inferior_Temporal_Lobe | | SE_08781 | chr2:145212225-145212954 | Brain_Mid_Frontal_Lobe | | SE_09144 | chr2:145176556-145221318 | CD14 | | SE_11384 | chr2:145208702-145218754 | CD20 | | SE_13334 | chr2:145212348-145213153 | CD34_Primary_RO01536 | | SE_13334 | chr2:145214186-145214916 | CD34_Primary_RO01536 | | SE_20010 | chr2:145209183-145221155 | CD56 | | SE_22321 | chr2:145209170-145241141 | CD8_primiary | | SE_26195 | chr2:145208502-145218704 | Duodenum_Smooth_Muscle | | SE_37250 | chr2:145209337-145212670 | HSMMtube | | SE_37250 | chr2:145213365-145215328 | HSMMtube | | SE_45982 | chr2:145209246-145221181 | Osteoblasts | | SE_53346 | chr2:145211995-145213210 | Spleen | | SE_53346 | chr2:145214108-145215274 | Spleen | | SE_58795 | chr2:145182294-145230606 | Ly1 | | SE_64101 | chr2:145211685-145213287 | HSMM | | SE_64101 | chr2:145213483-145214875 | HSMM |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr2 | 145213443 | 145214567 | | chr2 | 145214152 | 145214623 |
|
Enhancer Sequence | TATTCTAAAA GCTTCAACCC TGCTCAGAAT GTAGGGATTT TGTTTGAACC CAGGATTTTC 60
AAAGTTGGGA GAGAATCCAT GAAATGATCC CTCGTTCCTG TAAATGTACA CACATGGGTG 120
TGCCTGCCTA CACCATCAGA GCATCACACA CACACACCCT GCACACACAT CACCACACAC 180
ACCCTCTATG CTAAATCTGC CTTCAATTAA CCAAAAGCAC AATTTTGCCC TGACAGAGAA 240
GATTTCATTT GGTCCACATA TGACTAGGGA GCCGATTTCA TTTCCTGTAA AAAACCCCCT 300
CAAACGCTGC AAAGTTACCT GACTCAGCTG CTTGTAGAAA TCAAATTCAG TCAGAGATAA 360
CAGCTAATCA TTTGTCACAG TAAGAAGCAA TTCCCTGAAA TCGGAAGGGA AAACCTGCCG 420
CTTCAATCCG CAGGTCTGTC AGATTGCTAG AAATTACATT CTGCTCTGAC TAACCTCTGC 480
ACTTGGATTG CTAACAACAA GCAGCCTGCT CTATCAAAAG AGAATATCAT ACAACCAGGA 540
ACCGCTTTTG ATTCGTTCTG TTCCAATAAC CTGAGAAAAG TTTATGGACA TGCCTTGCTG 600
CCTGGACCTC AATTTCCACC AACCTGCACA CTGTTTTGAA TTTATAGCAC TGCAGCTCCA 660
TAGTAATGTA GGTAAAATTT ACAAGCTGAC TATCTGCTAC TTCATTGAAA GAAAATTAAG 720
AGTTGATTTT ATAACCACAC GACTGATATT TGCCTTCTGA TACTTTGAGG AAGCATACGG 780
TTTGGAAGCT TCAATTAAAA TGCCAAAAGA GAAAAAACAA ATTGATTAAC TCTCAAAATA 840
CAATTTATAT TTTTTAGAAA TGCTTCCCGG GAGGGAATTA ACTTTATACT CTTCTATGTA 900
AACACTATTT GTGCAGCATA AGTTTAATAA AAATGATACA TCACCTCTCT GTTAGGTTTA 960
TAATTTGCAT AGCAATAGTG AATATGGAAT TTTGGTCAAA ATGTTTCTCT CGTCTCTCTC 1020
TCTTTCTCTT TCTCTCCCTC CCCACATCTC TCCTGCAATA GTACAGGATC GTTGGAAATG 1080
GGTAAGTTTA ATATCTTTCC TAATCCCAAG AAGCCATTAT TATTACTTAA AGTATATCTC 1140
AAGGTAGGTT ATTAACCCCC AAGAAGTTAC AGCTTTGAGT TAGAATCACA TAATCTTAAA 1200
AAAGGACAAC ATATTTTCCA AGCAGTACTT AACCAAATAC TCTTCTTTAA CTCTGACTAG 1260
ATTTATGATG AATACAGATA TTGCAACTCT TATAAGAACT TAAAGATGGC GAACTCAGAG 1320
ATTCAGCATT TAAGAAGGCT GCCTCTAAGA CTAAGACTAA ATCCATCCCA AGTTTGTTCC 1380
ATTGTTTTTT TTTTTTAAAG CATTTTATTT TCCACAGTTG GAATCAGCTG AGGATACAGT 1440
GTGAGCAGTG ACTCTGAATT TCCTTTGCTT TTGTCAAACT GTGTCACAAC CATAAAGTTA 1500
TTTTAACTGA GTTTATTTGC CTAGGCATTT CCTTTCTCTT GTAGTAGTGT AAGAGAAAGG 1560
AAAACAACCA TTTAAAATGT AAGTACAGTT GAGTGGATAT AAGGGACTCT TCCAGCTCCT 1620
ATCGTAAGCA GACAATTCGA TGATAAGTAT GTGGGCTTTT TAAGCTTTAA AAAATATTCA 1680
TAAATCCCTT TTTGGATTCT TTCATTTCAA TTTTCTTCAA GCAATGAGAA TTAGACAAGT 1740
TTATAAATTC TCATTTCTAC CTTTCTTGGG CCAGTCCTGA TTACTCTTAT CATGGTTAAT 1800
ACTGGTTCAC ATGGGGGACT TCCACAAATT CTTTAATATA CTGTGTATCT GGTGTAAAAA 1860
AAATTATGTA AAATACAATA ATTGATGCTA TTAATGTATT TGGTGAGATA ATCTAATAGA 1920
TTTCCTTGAA GTAACTCTAA TAAATTTTTC TTCCTTAGTA AAAACAACCC CTTGGTCTTA 1980
GATTCTGCTC TTGTACAGTC ATCCGTACAG TGGCCAGGGC TTAAGCTCTG GTACTGTATG 2040
AGTATGCAAA CAAGCAGATT TCACAATCAG ATGACACTGA GACTTAGGCT TACTGTGCCA 2100
GACTCTCTTT GGTGACTGTT CTCTCATCTT GGGCCAGCCT AGGGATCTGA GAACCTGCTG 2160
TAGTTAGAAA GAAGTCACCT GACCTCGAAG TTTCCCTCCT GTCTTTTCTC AATCGTTCCA 2220
GCTCTCACAC TCAAGAGTCA GAGCTCTCCA CCACTGTCCT GGCCAGAGCA GCACCCCCCA 2280
AAGGTCTGCA TGTACCTCTG GCAAGATAAA TGCATATAGA AGACAATGCA TTTTTAGTCC 2340
CTATAGACTT TCTATAACGT CTACGTTTCC AGAATCTCAT GTGTGCCTTA AAAACCCTTT 2400
TCTTCTACAT TTAAAAGGAC AGTTTGATTA TATAATAATA CCTGGATTTA TGCATTAATC 2460
CACTGACAGC AGAGCCCGTT AATAGACATT TTTCCACTTG CTCCTCATAA CAAACCTTTG 2520
AAGGGGGGAG CAATTATTAT GAGGATGATT TTATAGATGA GTAAATTGAA TCTCAGAAAT 2580
TTTAACTGAC TTTTTCCCAC ATCACCTCGT GTTAGAATCT GGATCTGATT CCTGACTCCA 2640
GAAACTATTT GTCTCTAGAT TCTATCTGTG CTCTCTTCAT CACCTTGGGT GTACAAATCT 2700
AAGTGAGCAA ACAAAAGCCA AAATAGGATT TTTAACTATT TAACAGAGTA TGGTGGTGTC 2760
AGTATGAAAT CTTGTTCATC TGGTTTAGTG GACATAACTG TGCCTGGGCA GAAGAGAGAA 2820
GGAGGAGAGA AGAACAAAGG CAAGGTCAAG AGCAACTACA CTGAAATTGG GAGAAAAAGC 2880
AAGTTAGATA TAAGGAAGAG GACCTGGTAT GTAACAGGTA TTAATGGGAT CAGTGACATC 2940
CATCATTTGT GAATGGAACA 2960
|
